(Last updated : 2024-10-07 16:17:53)
  Miwa Kawanaka
   Department   Kawasaki Medical School  Kawasaki Medical School, Department of General Internal Medicine 2,
   Position   Associate Professor
■ Journal
1. 2024/08/08 Serum Cytokeratin 18 Fragment is an Indicator for Treating Metabolic Dysfunction associated Steatotic Liver Disease 
2. 2024/07/25 Identification of risk groups for advanced liver fibrosis in the general population using the Fibrosis-3 index 
3. 2024/07/01 Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction–Associated Steatotic Liver Disease 
4. 2024/06/01 Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in Japan 
5. 2024/04/25 Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease 
Display all(105)
■ Presentation
1. 2024/05/20 Long-term follow study of the esophagogastric junction- a study on the development of short segment barrett esophagus and its extension (Poster notice,Panelist at Symposium/Workshop (Other)) 
2. 2024/03/27 Cross-sectional study in general population for prevalence and LSM distribution of MASLD (Poster notice,General) 
3. 2024/03/27 Hepatic lobular inflammation is the most impacted prognostic factor in MAFLD: A Multi-Center study (Speech,Panelist at Symposium/Workshop (Applied)) 
4. 2024/03/27 Impact of single nucleotide polymorphisms on long-term prognosis in non-obese MASLD (Speech,General) 
5. 2024/03/27 Prognosis of patients with biopsy-confirmed MASLD - A multicenter study (Poster notice,General) 
Display all(41)